CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 21.70
-0.76 (-3.38%)
At close: Apr 29, 2026
CF PharmTech Revenue
In the year 2025, CF PharmTech had annual revenue of 432.52M CNY, down -28.83%.
Revenue
432.52M CNY
Revenue Growth
-28.83%
P/S Ratio
19.20
Revenue / Employee
714.91K CNY
Employees
605
Market Cap
9.24B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 432.52M | -175.23M | -28.83% |
| Dec 31, 2024 | 607.75M | 51.33M | 9.23% |
| Dec 31, 2023 | 556.42M | 207.29M | 59.37% |
| Dec 31, 2022 | 349.13M | 307.14M | 731.54% |
| Dec 31, 2021 | 41.99M | 37.13M | 764.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| Shandong Xinhua Pharmaceutical Company | 9.74B |
| Luye Pharma Group | 7.02B |
| SSY Group | 4.17B |
| China Shineway Pharmaceutical Group | 3.49B |
| Sihuan Pharmaceutical Holdings Group | 2.91B |
| Edding Genor Group Holdings | 2.77B |
| CanSino Biologics | 1.19B |